| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-43546-0.5mg | |||
| Biotin | NBP1-43546-0.1mg | |||
| PE/Cy5 | NBP1-43068-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43303-0.1mg | |||
| BSA Free | NBP1-43303-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-22436-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76843-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70378 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-94494-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-93746-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52437-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61748-0.025ml | |||
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy7 conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 micrograms of Rat IgG2a ? Isotype Control PE-Cy7 (left) or 0.06 micrograms of Anti-Mouse IgM PE-Cy7 (right). Cells in the ly](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0008.jpg "Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy7 conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 micrograms of Rat IgG2a ? Isotype Control PE-Cy7 (left) or 0.06 micrograms of Anti-Mouse IgM PE-Cy7 (right). Cells in the ly")
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Staining of C57BL/6 splenocytes with 0.5 ug of Rat IgG2a kappa Isotype Control Purified (open histogram) or 0.5 ug of Anti-Mouse IgM Purified (filled histogram) followed by Anti-Rat IgG Biotin and Streptavidin PE. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0001.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Allophycocyanin conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.125 ug of Rat IgG2a K Isotype Control APC (left) or 0.125 ug of Anti-Mouse IgM APC (right). Cells in the small scatter](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0002.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Allophycocyanin conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.125 ug of Rat IgG2a K Isotype Control APC (left) or 0.125 ug of Anti-Mouse IgM APC (right). Cells in the small scatter](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0003.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Biotin conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.06 ug of Rat IgG2a kappa Isotype Control Biotin (left) or 0.06 ug of Anti-Mouse IgM Biotin (right) followed by Streptavidin PE .](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0004.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of FITC conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.125 ug of Rat IgG2a K Isotype Control FITC (left) or 0.125 ug of Anti-Mouse IgM FITC (right). Total viable cells were used for ana](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0005.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE conjugate of NBP1-43303. The II/41 antibody has been tested by flow cytometric mouse spleen cell suspension. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0006.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy5 conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 ug of Rat IgG2a Isotype Control PE-Cy5 (left) or 0.06 ug of Anti-Mouse IgM PE-Cy5 (right). Total viable cells were used for](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of BAF-3 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of BAF-3 cells (right) compared to a negative control without primary antibody (left).")
![Flow Cytometry: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 in Hela cells (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Flow-Cytometry-NBP2-22436-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of Hela cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane and cytoplasm of NIH-3T3 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0005.jpg)
![Flow Cytometry: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 in mouse splenocytes (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Flow-Cytometry-NBP2-22436-img0001.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human BAFF recombinant protein per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (Lane 1: 0.25 ug/mL; Lane 2: 0.5 ug/mL and Lane 3: 1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed at around 18kDa.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NBP1-76843-img0005.jpg "<b>Expression of Tagged Proteins Validation. </b>Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human BAFF recombinant protein per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (Lane 1: 0.25 ug/mL; Lane 2: 0.5 ug/mL and Lane 3: 1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed at around 18kDa.")
![<b>Expression of Tagged Proteins Validation. </b>Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation in Human, Mouse and Rat Cell Lines. Loading: 15 ug of lysates per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NBP1-76843-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation of BAFF/BLyS/TNFSF13B in HL60 Cells. Immunocytochemical analysis of HL60 cells using anti-BAFF/BLyS/TNFSF13B antibody at 1 ug/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-271120242010580.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation in Human HL60 Cell Lysate (H) and Mouse Spleen Lysate (M). Loading: 15 ug of lysates per lane.Antibodies: BAFF/BLyS/TNFSF13B (1 u/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-2711202420285892.jpg)
![Immunocytochemistry/ Immunofluorescence: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation of BAFF/BLyS/TNFSF13B in Human Spleen Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed human spleen tissue labeling BAFF/BLyS/TNFSF13B with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-2711202420285848.gif)
![Western Blot: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD40.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Western-Blot-NBP2-46150-img0013.jpg "Western Blot: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD40.")
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0012.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0001.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0002.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0003.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0004.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0005.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human liver tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0006.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0007.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0008.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0009.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0010.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0011.jpg)
![Western Blot: ILF1 Antibody [NB100-1285] - (0.3ug/ml) staining of Human Thymus lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/ILF1-Antibody-Western-Blot-NB100-1285-img0002.jpg "Western Blot: ILF1 Antibody [NB100-1285] - (0.3ug/ml) staining of Human Thymus lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: ILF1 Antibody [NB100-1285] - Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing nuclear and cytoplasmic/vesicle staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/ILF1-Antibody-Immunocytochemistry-Immunofluorescence-NB100-1285-img0004.jpg)
![Flow Cytometry: ILF1 Antibody [NB100-1285] - Flow cytometric analysis of paraformaldehyde fixed HeLa cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/ILF1-Antibody-Flow-Cytometry-NB100-1285-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: ILF1 Antibody [NB100-1285] - Immunofluorescence analysis of paraformaldehyde fixed U2OS cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing nuclear and cytoplasmic/vesicle staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/ILF1-Antibody-Immunocytochemistry-Immunofluorescence-NB100-1285-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: Clusterin/APOJ Antibody [NBP1-06027] - Immunofluorescence analysis of paraformaldehyde fixed PC12 suspension cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/nbp1-06027_goat-polyclonal-clusterin-apoj-antibody-16520239183316.jpg "Immunocytochemistry/Immunofluorescence: Clusterin/APOJ Antibody [NBP1-06027] - Immunofluorescence analysis of paraformaldehyde fixed PC12 suspension cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).")
![Western Blot: Clusterin/APOJ Antibody [NBP1-06027] - (0.1ug/ml) staining of Mouse (A) and (0.3ug/ml) Rat (B) Brain lysate (35ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp1-06027_goat-polyclonal-clusterin-apoj-antibody-1652023918330.jpg)
![Immunocytochemistry/Immunofluorescence: ATR [p Ser428] Antibody [NBP3-05447] - Immunofluorescence analysis of U2OS cells using ATR antibody (NBP3-05447) at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-05447-img0001.jpg "Immunocytochemistry/Immunofluorescence: ATR [p Ser428] Antibody [NBP3-05447] - Immunofluorescence analysis of U2OS cells using ATR antibody (NBP3-05447) at dilution of 1:100. Blue: DAPI for nuclear staining.")
![Immunohistochemistry-Paraffin: ATR [p Ser428] Antibody [NBP3-05447] - Rat testis using ATR Rabbit pAb (NBP3-05447) at dilution of 1:100 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunohistochemistry-Paraffin-NBP3-05447-img0005.jpg)
![Immunohistochemistry-Paraffin: ATR [p Ser428] Antibody [NBP3-05447] - Human testis using ATR Rabbit pAb (NBP3-05447) at dilution of 1:100 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunohistochemistry-Paraffin-NBP3-05447-img0003.jpg)
![Immunohistochemistry-Paraffin: ATR [p Ser428] Antibody [NBP3-05447] - Mouse testis using ATR Rabbit pAb (NBP3-05447) at dilution of 1:100 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunohistochemistry-Paraffin-NBP3-05447-img0004.jpg)
![Western Blot: ATR [p Ser428] Antibody [NBP3-05447] - Analysis of 293T, using Phospho-ATR-S428 antibody at 1:400 dilution.293T cells were treated by UV at room temperature for 15-30 minutes. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/antibody/nbp3-05447_rabbit-polyclonal-atr-p-ser428-antibody-western-blot-265202385445.jpg)
![Western Blot: ATR [p Ser428] Antibody [NBP3-05447] - Analysis of NIH/3T3, using Phospho-ATR-S428 antibody at 1:400 dilution.NIH/3T3 cells were treated by Nocodazole (50 ng/ml) at 37 for 20 hours.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/antibody/nbp3-05447_rabbit-polyclonal-atr-p-ser428-antibody-western-blot-265202385627.jpg)
![Western Blot: SNRPD1 Antibody [NBP2-94494] - Western blot analysis of extracts of various cell lines, using SNRPD1 antibody (NBP2-94494) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/SNRPD1 Antibody-Western Blot-NBP2-94494-img0004.jpg "Western Blot: SNRPD1 Antibody [NBP2-94494] - Western blot analysis of extracts of various cell lines, using SNRPD1 antibody (NBP2-94494) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.")
![Immunohistochemistry-Paraffin: SNRPD1 Antibody [NBP2-94494] - Immunohistochemistry of paraffin-embedded rat kidney using SNRPD1 Rabbit pAb (NBP2-94494) at dilution of 1:50 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/SNRPD1-Antibody-Immunohistochemistry-Paraffin-NBP2-94494-img0003.jpg)
![Immunohistochemistry-Paraffin: SNRPD1 Antibody [NBP2-94494] - Immunohistochemistry of paraffin-embedded human breast cancer using SNRPD1 Rabbit pAb (NBP2-94494) at dilution of 1:50 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/SNRPD1-Antibody-Immunohistochemistry-Paraffin-NBP2-94494-img0001.jpg)
![Immunohistochemistry-Paraffin: SNRPD1 Antibody [NBP2-94494] - Immunohistochemistry of paraffin-embedded mouse kidney using SNRPD1 Rabbit pAb (NBP2-94494) at dilution of 1:50 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/SNRPD1-Antibody-Immunohistochemistry-Paraffin-NBP2-94494-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: SNRPD1 Antibody - Azide and BSA Free [SNRPD1] - Immunofluorescence analysis of U2OS cells using SNRPD1 Rabbit pAb at dilution of 1:50 (40x lens). Secondary antibody: Cy3 Goat Anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp2-94494_rabbit-polyclonal-snrpd1-antibody-52202516283292.jpg)
![Immunocytochemistry/ Immunofluorescence: SNRPD1 Antibody - Azide and BSA Free [SNRPD1] - Immunofluorescence analysis of HeLa cells using SNRPD1 Rabbit pAb at dilution of 1:50 (40x lens). Secondary antibody: Cy3 Goat Anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp2-94494_rabbit-polyclonal-snrpd1-antibody-52202516345276.jpg)
![Immunocytochemistry/Immunofluorescence: SEL1L Antibody [NBP2-93746] - Analysis of L929 cells using SEL1L at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/SEL1L-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-93746-img0002.jpg "Immunocytochemistry/Immunofluorescence: SEL1L Antibody [NBP2-93746] - Analysis of L929 cells using SEL1L at dilution of 1:100. Blue: DAPI for nuclear staining.")
![Immunocytochemistry/Immunofluorescence: SEL1L Antibody [NBP2-93746] - Analysis of C6 cells using SEL1L at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/SEL1L-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-93746-img0001.jpg)
![Western Blot: CD44 Antibody (9W6E7) [CD44] - Western blot analysis of various lysates using CD44 Rabbit mAb at 1:20000 dilution incubated overnight at 4C.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit .Exposure time: 45s.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-5220251734544.jpg "Western Blot: CD44 Antibody (9W6E7) [CD44] - Western blot analysis of various lysates using CD44 Rabbit mAb at 1:20000 dilution incubated overnight at 4C.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit .Exposure time: 45s.")
![Immunohistochemistry: CD44 Antibody (9W6E7) [CD44] - Immunohistochemistry analysis of paraffin-embedded Human liver cancer using CD44 Rabbit mAb at dilution of 1:2000 (40x lens). High pressure antigen retrieval performed with 0.01M Tris/EDTA Buffer (pH 9.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517315598.jpg)
![Immunohistochemistry: CD44 Antibody (9W6E7) [CD44] - Immunohistochemistry analysis of paraffin-embedded Human skin using CD44 Rabbit mAb at dilution of 1:2000 (40x lens). High pressure antigen retrieval performed with 0.01M Tris/EDTA Buffer (pH 9.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517344236.jpg)
![Immunocytochemistry/ Immunofluorescence: CD44 Antibody (9W6E7) [CD44] - Confocal imaging of HeLa cells using CD44 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . The cells were counterstained with alpha-Tubulin Mouse mAb followed by incubation with ABflo 488-conjugated Goat Anti-Mouse IgG (H+L) Ab (Green). DAPI was used for nuclear staining (Blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517352722.jpg)
![Flow Cytometry: CD44 Antibody (9W6E7) [CD44] - Flow cytometry: 1X10^6 Jurkat cells (negative control,left) and HeLa cells were surface-stained with CD44 Rabbit mAb or ABflo 647 Rabbit IgG isotype control , followed by Alexa Fluor 647 conjugated goat anti-rabbit pAb staining. Non-fluorescently stained cells were used as blank control .](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-5220251735270.jpg)
![Flow Cytometry: CD44 Antibody (9W6E7) [CD44] - Flow cytometry: 1X10^6 HeLa cells were surface-stained with ABflo 647 Rabbit IgG isotype control or CD44 Rabbit mAb .](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517304969.jpg)
![Western Blot: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis using CD168 mAb against HEK293 (1) and CD168 (AA: 306-497)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Western-Blot-NBP2-52437-img0003.jpg "Western Blot: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis using CD168 mAb against HEK293 (1) and CD168 (AA: 306-497)-hIgGFc transfected HEK293 (2) cell lysate.")
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - An intracellular stain was performed on Jurkat cells with RHAMM/CD168 Antibody (2F2C9) NBP2-52437AF488 and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 488.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0007.jpg)
![Western Blot: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis using CD168 mAb against human CD168 (AA: 306-497) recombinant protein. (Expected MW is 48.3 kDa)](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Western-Blot-NBP2-52437-img0002.jpg)
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis of Hela cells using CD168 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0001.jpg)
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - An intracellular stain was performed on A549 cells with RHAMM/CD168 Antibody (2F2C9) NBP2-52437PE and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0005.jpg)
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - An intracellular stain was performed on Jurkat cells with RHAMM/CD168 Antibody (2F2C9) NBP2-52437PE and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0006.jpg)
![ELISA: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-ELISA-NBP2-52437-img0004.jpg)
![Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mAb against HEK293 (1) and P2RX7 (AA: 226-452)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Western-Blot-NBP2-61748-img0005.jpg "Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mAb against HEK293 (1) and P2RX7 (AA: 226-452)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry-Paraffin: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis of esophageal cancer tissues using P2RX7 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Immunohistochemistry-NBP2-61748-img0003.jpg)
![Flow Cytometry: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis of Hela cells using P2RX7 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Flow-Cytometry-NBP2-61748-img0002.jpg)
![Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mAb against human P2RX7 (AA: 226-452) recombinant protein. (Expected MW is 48.9 kDa)](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Western-Blot-NBP2-61748-img0004.jpg)
![Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mouse mAb against A431 (1), U251 (2), Hela (3), U937 (4), and HepG2 (5) cell lysate.](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Western-Blot-NBP2-61748-img0006.jpg)
![ELISA: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-ELISA-NBP2-61748-img0001.jpg)